Sen. Heather Steans

Filed: 4/23/2009

 

 


 

 


 
09600HB0445sam002 LRB096 04780 RLC 25523 a

1
AMENDMENT TO HOUSE BILL 445

2     AMENDMENT NO. ______. Amend House Bill 445 by replacing
3 everything after the enacting clause with the following:
 
4     "Section 5. The Illinois Controlled Substances Act is
5 amended by changing Sections 102, 201, 202, 205, 207, 209, 211,
6 214, 301, 302, 303, 303.05, 303.1, 304, 305, 306, 309, 312,
7 313, 318, 405, 405.1, 410, 501, 501.1, 505, and 507 as follows:
 
8     (720 ILCS 570/102)  (from Ch. 56 1/2, par. 1102)
9     Sec. 102. Definitions. As used in this Act, unless the
10 context otherwise requires:
11     (a) "Addict" means any person who habitually uses any drug,
12 chemical, substance or dangerous drug other than alcohol so as
13 to endanger the public morals, health, safety or welfare or who
14 is so far addicted to the use of a dangerous drug or controlled
15 substance other than alcohol as to have lost the power of self
16 control with reference to his or her addiction.

 

 

09600HB0445sam002 - 2 - LRB096 04780 RLC 25523 a

1     (b) "Administer" means the direct application of a
2 controlled substance, whether by injection, inhalation,
3 ingestion, or any other means, to the body of a patient,
4 research subject, or animal (as defined by the Humane
5 Euthanasia in Animal Shelters Act) by:
6         (1) a practitioner (or, in his or her presence, by his
7     or her authorized agent),
8         (2) the patient or research subject at the lawful
9     direction of the practitioner, or
10         (3) a euthanasia technician as defined by the Humane
11     Euthanasia in Animal Shelters Act.
12     (c) "Agent" means an authorized person who acts on behalf
13 of or at the direction of a manufacturer, distributor, or
14 dispenser. It does not include a common or contract carrier,
15 public warehouseman or employee of the carrier or warehouseman.
16     (c-1) "Anabolic Steroids" means any drug or hormonal
17 substance, chemically and pharmacologically related to
18 testosterone (other than estrogens, progestins, and
19 corticosteroids) that promotes muscle growth. , and includes:
20             (i) boldenone,
21             (ii) chlorotestosterone,
22             (iii) chostebol,
23             (iv) dehydrochlormethyltestosterone,
24             (v) dihydrotestosterone,
25             (vi) drostanolone,
26             (vii) ethylestrenol,

 

 

09600HB0445sam002 - 3 - LRB096 04780 RLC 25523 a

1             (viii) fluoxymesterone,
2             (ix) formebulone,
3             (x) mesterolone,
4             (xi) methandienone,
5             (xii) methandranone,
6             (xiii) methandriol,
7             (xiv) methandrostenolone,
8             (xv) methenolone,
9             (xvi) methyltestosterone,
10             (xvii) mibolerone,
11             (xviii) nandrolone,
12             (xix) norethandrolone,
13             (xx) oxandrolone,
14             (xxi) oxymesterone,
15             (xxii) oxymetholone,
16             (xxiii) stanolone,
17             (xxiv) stanozolol,
18             (xxv) testolactone,
19             (xxvi) testosterone,
20             (xxvii) trenbolone, and
21             (xxviii) any salt, ester, or isomer of a drug or
22         substance described or listed in this paragraph, if
23         that salt, ester, or isomer promotes muscle growth.
24     Any person who is otherwise lawfully in possession of an
25 anabolic steroid, or who otherwise lawfully manufactures,
26 distributes, dispenses, delivers, or possesses with intent to

 

 

09600HB0445sam002 - 4 - LRB096 04780 RLC 25523 a

1 deliver an anabolic steroid, which anabolic steroid is
2 expressly intended for and lawfully allowed to be administered
3 through implants to livestock or other nonhuman species, and
4 which is approved by the Secretary of Health and Human Services
5 for such administration, and which the person intends to
6 administer or have administered through such implants, shall
7 not be considered to be in unauthorized possession or to
8 unlawfully manufacture, distribute, dispense, deliver, or
9 possess with intent to deliver such anabolic steroid for
10 purposes of this Act.
11     (d) "Administration" means the Drug Enforcement
12 Administration, United States Department of Justice, or its
13 successor agency.
14     (e) "Control" means to add a drug or other substance, or
15 immediate precursor, to a Schedule under Article II of this Act
16 whether by transfer from another Schedule or otherwise.
17     (f) "Controlled Substance" means a drug, substance, or
18 immediate precursor in the Schedules of Article II of this Act.
19     (g) "Counterfeit substance" means a controlled substance,
20 which, or the container or labeling of which, without
21 authorization bears the trademark, trade name, or other
22 identifying mark, imprint, number or device, or any likeness
23 thereof, of a manufacturer, distributor, or dispenser other
24 than the person who in fact manufactured, distributed, or
25 dispensed the substance.
26     (h) "Deliver" or "delivery" means the actual, constructive

 

 

09600HB0445sam002 - 5 - LRB096 04780 RLC 25523 a

1 or attempted transfer of possession of a controlled substance,
2 with or without consideration, whether or not there is an
3 agency relationship.
4     (i) "Department" means the Illinois Department of Human
5 Services (as successor to the Department of Alcoholism and
6 Substance Abuse) or its successor agency.
7     (j) "Department of State Police" means the Department of
8 State Police of the State of Illinois or its successor agency.
9     (k) "Department of Corrections" means the Department of
10 Corrections of the State of Illinois or its successor agency.
11     (l) "Department of Financial and Professional Regulation"
12 means the Department of Financial and Professional Regulation
13 of the State of Illinois or its successor agency.
14     (m) "Depressant" or "stimulant substance" means:
15         (1) a drug which contains any quantity of (i)
16     barbituric acid or any of the salts of barbituric acid
17     which has been designated as habit forming under section
18     502 (d) of the Federal Food, Drug, and Cosmetic Act (21
19     U.S.C. 352 (d)); or
20         (2) a drug which contains any quantity of (i)
21     amphetamine or methamphetamine and any of their optical
22     isomers; (ii) any salt of amphetamine or methamphetamine or
23     any salt of an optical isomer of amphetamine; or (iii) any
24     substance which the Department, after investigation, has
25     found to be, and by rule designated as, habit forming
26     because of its depressant or stimulant effect on the

 

 

09600HB0445sam002 - 6 - LRB096 04780 RLC 25523 a

1     central nervous system; or
2         (3) lysergic acid diethylamide; or
3         (4) any drug which contains any quantity of a substance
4     which the Department, after investigation, has found to
5     have, and by rule designated as having, a potential for
6     abuse because of its depressant or stimulant effect on the
7     central nervous system or its hallucinogenic effect.
8     (n) (Blank).
9     (o) "Director" means the Director of the Department of
10 State Police or the Department of Professional Regulation or
11 his or her designated agents.
12     (p) "Dispense" means to deliver a controlled substance to
13 an ultimate user or research subject by or pursuant to the
14 lawful order of a prescriber, including the prescribing,
15 administering, packaging, labeling, or compounding necessary
16 to prepare the substance for that delivery.
17     (q) "Dispenser" means a practitioner who dispenses.
18     (r) "Distribute" means to deliver, other than by
19 administering or dispensing, a controlled substance.
20     (s) "Distributor" means a person who distributes.
21     (t) "Drug" means (1) substances recognized as drugs in the
22 official United States Pharmacopoeia, Official Homeopathic
23 Pharmacopoeia of the United States, or official National
24 Formulary, or any supplement to any of them; (2) substances
25 intended for use in diagnosis, cure, mitigation, treatment, or
26 prevention of disease in man or animals; (3) substances (other

 

 

09600HB0445sam002 - 7 - LRB096 04780 RLC 25523 a

1 than food) intended to affect the structure of any function of
2 the body of man or animals and (4) substances intended for use
3 as a component of any article specified in clause (1), (2), or
4 (3) of this subsection. It does not include devices or their
5 components, parts, or accessories.
6     (t-1) "Drug Schedule" means the classification system
7 established by the federal Food and Drug Administration and the
8 federal Drug Enforcement Administration.
9     (t-5) "Euthanasia agency" means an entity certified by the
10 Department of Financial and Professional Regulation for the
11 purpose of animal euthanasia that holds an animal control
12 facility license or animal shelter license under the Animal
13 Welfare Act. A euthanasia agency is authorized to purchase,
14 store, possess, and utilize Schedule II nonnarcotic and
15 Schedule III nonnarcotic drugs for the sole purpose of animal
16 euthanasia.
17     (t-10) "Euthanasia drugs" means Schedule II or Schedule III
18 substances (nonnarcotic controlled substances) that are used
19 by a euthanasia agency for the purpose of animal euthanasia.
20     (u) "Good faith" means the prescribing or dispensing of a
21 controlled substance by a practitioner in the regular course of
22 professional treatment to or for any person who is under his or
23 her treatment for a pathology or condition other than that
24 individual's physical or psychological dependence upon or
25 addiction to a controlled substance, except as provided herein:
26 and application of the term to a pharmacist shall mean the

 

 

09600HB0445sam002 - 8 - LRB096 04780 RLC 25523 a

1 dispensing of a controlled substance pursuant to the
2 prescriber's order which in the professional judgment of the
3 pharmacist is lawful. The pharmacist shall be guided by
4 accepted professional standards including, but not limited to
5 the following, in making the judgment:
6         (1) lack of consistency of doctor-patient
7     relationship,
8         (2) frequency of prescriptions for same drug by one
9     prescriber for large numbers of patients,
10         (3) quantities beyond those normally prescribed,
11         (4) unusual dosages,
12         (5) unusual geographic distances between patient,
13     pharmacist and prescriber,
14         (6) consistent prescribing of habit-forming drugs.
15     (u-1) "Home infusion services" means services provided by a
16 pharmacy in compounding solutions for direct administration to
17 a patient in a private residence, long-term care facility, or
18 hospice setting by means of parenteral, intravenous,
19 intramuscular, subcutaneous, or intraspinal infusion.
20     (v) "Immediate precursor" means a substance:
21         (1) which the Department has found to be and by rule
22     designated as being a principal compound used, or produced
23     primarily for use, in the manufacture of a controlled
24     substance;
25         (2) which is an immediate chemical intermediary used or
26     likely to be used in the manufacture of such controlled

 

 

09600HB0445sam002 - 9 - LRB096 04780 RLC 25523 a

1     substance; and
2         (3) the control of which is necessary to prevent,
3     curtail or limit the manufacture of such controlled
4     substance.
5     (w) "Instructional activities" means the acts of teaching,
6 educating or instructing by practitioners using controlled
7 substances within educational facilities approved by the State
8 Board of Education or its successor agency.
9     (x) "Local authorities" means a duly organized State,
10 County or Municipal peace unit or police force.
11     (y) "Look-alike substance" means a substance, other than a
12 controlled substance which (1) by overall dosage unit
13 appearance, including shape, color, size, markings or lack
14 thereof, taste, consistency, or any other identifying physical
15 characteristic of the substance, would lead a reasonable person
16 to believe that the substance is a controlled substance, or (2)
17 is expressly or impliedly represented to be a controlled
18 substance or is distributed under circumstances which would
19 lead a reasonable person to believe that the substance is a
20 controlled substance. For the purpose of determining whether
21 the representations made or the circumstances of the
22 distribution would lead a reasonable person to believe the
23 substance to be a controlled substance under this clause (2) of
24 subsection (y), the court or other authority may consider the
25 following factors in addition to any other factor that may be
26 relevant:

 

 

09600HB0445sam002 - 10 - LRB096 04780 RLC 25523 a

1         (a) statements made by the owner or person in control
2     of the substance concerning its nature, use or effect;
3         (b) statements made to the buyer or recipient that the
4     substance may be resold for profit;
5         (c) whether the substance is packaged in a manner
6     normally used for the illegal distribution of controlled
7     substances;
8         (d) whether the distribution or attempted distribution
9     included an exchange of or demand for money or other
10     property as consideration, and whether the amount of the
11     consideration was substantially greater than the
12     reasonable retail market value of the substance.
13     Clause (1) of this subsection (y) shall not apply to a
14 noncontrolled substance in its finished dosage form that was
15 initially introduced into commerce prior to the initial
16 introduction into commerce of a controlled substance in its
17 finished dosage form which it may substantially resemble.
18     Nothing in this subsection (y) prohibits the dispensing or
19 distributing of noncontrolled substances by persons authorized
20 to dispense and distribute controlled substances under this
21 Act, provided that such action would be deemed to be carried
22 out in good faith under subsection (u) if the substances
23 involved were controlled substances.
24     Nothing in this subsection (y) or in this Act prohibits the
25 manufacture, preparation, propagation, compounding,
26 processing, packaging, advertising or distribution of a drug or

 

 

09600HB0445sam002 - 11 - LRB096 04780 RLC 25523 a

1 drugs by any person registered pursuant to Section 510 of the
2 Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360).
3     (y-1) "Mail-order pharmacy" means a pharmacy that is
4 located in a state of the United States, other than Illinois,
5 that delivers, dispenses or distributes, through the United
6 States Postal Service or other common carrier, to Illinois
7 residents, any substance which requires a prescription.
8     (z) "Manufacture" means the production, preparation,
9 propagation, compounding, conversion or processing of a
10 controlled substance other than methamphetamine, either
11 directly or indirectly, by extraction from substances of
12 natural origin, or independently by means of chemical
13 synthesis, or by a combination of extraction and chemical
14 synthesis, and includes any packaging or repackaging of the
15 substance or labeling of its container, except that this term
16 does not include:
17         (1) by an ultimate user, the preparation or compounding
18     of a controlled substance for his or her own use; or
19         (2) by a practitioner, or his or her authorized agent
20     under his or her supervision, the preparation,
21     compounding, packaging, or labeling of a controlled
22     substance:
23             (a) as an incident to his or her administering or
24         dispensing of a controlled substance in the course of
25         his or her professional practice; or
26             (b) as an incident to lawful research, teaching or

 

 

09600HB0445sam002 - 12 - LRB096 04780 RLC 25523 a

1         chemical analysis and not for sale.
2     (z-1) (Blank).
3     (aa) "Narcotic drug" means any of the following, whether
4 produced directly or indirectly by extraction from substances
5 of natural origin, or independently by means of chemical
6 synthesis, or by a combination of extraction and chemical
7 synthesis:
8         (1) opium and opiate, and any salt, compound,
9     derivative, or preparation of opium or opiate;
10         (2) any salt, compound, isomer, derivative, or
11     preparation thereof which is chemically equivalent or
12     identical with any of the substances referred to in clause
13     (1), but not including the isoquinoline alkaloids of opium;
14         (3) opium poppy and poppy straw;
15         (4) coca leaves and any salts, compound, isomer, salt
16     of an isomer, derivative, or preparation of coca leaves
17     including cocaine or ecgonine, and any salt, compound,
18     isomer, derivative, or preparation thereof which is
19     chemically equivalent or identical with any of these
20     substances, but not including decocainized coca leaves or
21     extractions of coca leaves which do not contain cocaine or
22     ecgonine (for the purpose of this paragraph, the term
23     "isomer" includes optical, positional and geometric
24     isomers).
25     (bb) "Nurse" means a registered nurse licensed under the
26 Nurse Practice Act.

 

 

09600HB0445sam002 - 13 - LRB096 04780 RLC 25523 a

1     (cc) (Blank).
2     (dd) "Opiate" means any substance having an addiction
3 forming or addiction sustaining liability similar to morphine
4 or being capable of conversion into a drug having addiction
5 forming or addiction sustaining liability.
6     (ee) "Opium poppy" means the plant of the species Papaver
7 somniferum L., except its seeds.
8     (ff) "Parole and Pardon Board" means the Parole and Pardon
9 Board of the State of Illinois or its successor agency.
10     (gg) "Person" means any individual, corporation,
11 mail-order pharmacy, government or governmental subdivision or
12 agency, business trust, estate, trust, partnership or
13 association, or any other entity.
14     (hh) "Pharmacist" means any person who holds a license or
15 certificate of registration as a registered pharmacist, a local
16 registered pharmacist or a registered assistant pharmacist
17 under the Pharmacy Practice Act.
18     (ii) "Pharmacy" means any store, ship or other place in
19 which pharmacy is authorized to be practiced under the Pharmacy
20 Practice Act.
21     (jj) "Poppy straw" means all parts, except the seeds, of
22 the opium poppy, after mowing.
23     (kk) "Practitioner" means a physician licensed to practice
24 medicine in all its branches, dentist, optometrist,
25 podiatrist, veterinarian, scientific investigator, pharmacist,
26 physician assistant, advanced practice nurse, licensed

 

 

09600HB0445sam002 - 14 - LRB096 04780 RLC 25523 a

1 practical nurse, registered nurse, hospital, laboratory, or
2 pharmacy, or other person licensed, registered, or otherwise
3 lawfully permitted by the United States or this State to
4 distribute, dispense, conduct research with respect to,
5 administer or use in teaching or chemical analysis, a
6 controlled substance in the course of professional practice or
7 research.
8     (ll) "Pre-printed prescription" means a written
9 prescription upon which the designated drug has been indicated
10 prior to the time of issuance and does not mean a written
11 prescription which is machine or computer generated
12 individually in the prescriber's office.
13     (mm) "Prescriber" means a physician licensed to practice
14 medicine in all its branches, dentist, optometrist, podiatrist
15 or veterinarian who issues a prescription, a physician
16 assistant who issues a prescription for a Schedule III, IV, or
17 V controlled substance in accordance with Section 303.05 and
18 the written guidelines required under Section 7.5 of the
19 Physician Assistant Practice Act of 1987, or an advanced
20 practice nurse with prescriptive authority delegated under
21 Section 65-40 of the Nurse Practice Act and in accordance with
22 Section 303.05 and a written collaborative agreement under
23 Section 65-35 of the Nurse Practice Act.
24     (nn) "Prescription" means a lawful written, facsimile, or
25 verbal order of a physician licensed to practice medicine in
26 all its branches, dentist, podiatrist or veterinarian for any

 

 

09600HB0445sam002 - 15 - LRB096 04780 RLC 25523 a

1 controlled substance, of an optometrist for a Schedule III, IV,
2 or V controlled substance in accordance with Section 15.1 of
3 the Illinois Optometric Practice Act of 1987, of a physician
4 assistant for a Schedule III, IV, or V controlled substance in
5 accordance with Section 303.05 and the written guidelines
6 required under Section 7.5 of the Physician Assistant Practice
7 Act of 1987, or of an advanced practice nurse with prescriptive
8 authority delegated under Section 65-40 of the Nurse Practice
9 Act who issues a prescription for a Schedule III, IV, or V
10 controlled substance in accordance with Section 303.05 and a
11 written collaborative agreement under Section 65-35 of the
12 Nurse Practice Act.
13     (oo) "Production" or "produce" means manufacture,
14 planting, cultivating, growing, or harvesting of a controlled
15 substance other than methamphetamine.
16     (pp) "Registrant" means every person who is required to
17 register under Section 302 of this Act.
18     (qq) "Registry number" means the number assigned to each
19 person authorized to handle controlled substances under the
20 laws of the United States and of this State.
21     (rr) "Secretary" means the Secretary of the Department of
22 Financial and Professional Regulation or the Department of
23 Human Services or his or her designated agents.
24     (ss) (rr) "State" includes the State of Illinois and any
25 state, district, commonwealth, territory, insular possession
26 thereof, and any area subject to the legal authority of the

 

 

09600HB0445sam002 - 16 - LRB096 04780 RLC 25523 a

1 United States of America.
2     (tt) (ss) "Ultimate user" means a person who lawfully
3 possesses a controlled substance for his or her own use or for
4 the use of a member of his or her household or for
5 administering to an animal owned by him or her or by a member
6 of his or her household.
7 (Source: P.A. 94-556, eff. 9-11-05; 95-242, eff. 1-1-08;
8 95-639, eff. 10-5-07; 95-689, eff. 10-29-07; 95-876, eff.
9 8-21-08.)
 
10     (720 ILCS 570/201)  (from Ch. 56 1/2, par. 1201)
11     Sec. 201. (a) The Department shall carry out the provisions
12 of this Article. The Department or its successor agency may add
13 substances to a drug schedule which is higher than the federal
14 schedule by administrative rule or delete or reschedule all
15 controlled substances in the Schedules of Sections 204, 206,
16 208, 210 and 212 of this Act. In making a determination
17 regarding the elevating addition, deletion, or rescheduling of
18 a substance, the Department shall consider the following:
19         (1) the actual or relative potential for abuse;
20         (2) the scientific evidence of its pharmacological
21     effect, if known;
22         (3) the state of current scientific knowledge
23     regarding the substance;
24         (4) the history and current pattern of abuse;
25         (5) the scope, duration, and significance of abuse;

 

 

09600HB0445sam002 - 17 - LRB096 04780 RLC 25523 a

1         (6) the risk to the public health;
2         (7) the potential of the substance to produce
3     psychological or physiological dependence;
4         (8) whether the substance is an immediate precursor of
5     a substance already controlled under this Article;
6         (9) the immediate harmful effect in terms of
7     potentially fatal dosage; and
8         (10) the long-range effects in terms of permanent
9     health impairment.
10     (b) (Blank).
11     (c) (Blank).
12     (d) If any substance is scheduled, rescheduled, or deleted
13 as a controlled substance under Federal law and notice thereof
14 is given to the Department, the Department shall similarly
15 control the substance under this Act after the expiration of 30
16 days from publication in the Federal Register of a final order
17 scheduling a substance as a controlled substance or
18 rescheduling or deleting a substance, unless within that 30 day
19 period the Department initiates action to elevate the schedule
20 for a specific controlled substance objects, or a party
21 adversely affected files with the Department substantial
22 written objections objecting to inclusion, rescheduling, or
23 deletion. In that case, the Department shall publish the
24 reasons for that action objection or the substantial written
25 objections and afford all interested parties an opportunity to
26 be heard. At the conclusion of the hearing, the Department

 

 

09600HB0445sam002 - 18 - LRB096 04780 RLC 25523 a

1 shall publish its decision, by means of a rule, which shall be
2 final unless altered by statute. Upon publication of objections
3 by the Department, similar control under this Act whether by
4 inclusion, rescheduling or deletion is stayed until the
5 Department publishes its ruling.
6     (e) (Blank). The Department shall by rule exclude any
7 non-narcotic substances from a schedule if such substance may,
8 under the Federal Food, Drug, and Cosmetic Act, be lawfully
9 sold over the counter without a prescription.
10     (f) (Blank).
11     (g) Authority to control under this section does not extend
12 to distilled spirits, wine, malt beverages, or tobacco as those
13 terms are defined or used in the Liquor Control Act and the
14 Tobacco Products Tax Act.
15     (h) Persons registered with the Drug Enforcement
16 Administration to manufacture or distribute controlled
17 substances shall maintain adequate security and provide
18 effective controls and procedures to guard against theft and
19 diversion, but shall not otherwise be required to meet the
20 physical security control requirements (such as cage or vault)
21 for Schedule V controlled substances containing
22 pseudoephedrine or Schedule II controlled substances
23 containing dextromethorphan.
24 (Source: P.A. 94-800, eff. 1-1-07; 94-1087, eff. 1-19-07;
25 95-331, eff. 8-21-07.)
 

 

 

09600HB0445sam002 - 19 - LRB096 04780 RLC 25523 a

1     (720 ILCS 570/202)  (from Ch. 56 1/2, par. 1202)
2     Sec. 202.
3     (a) The scheduled controlled substances shall be those
4 listed by the authorized federal agency. Any federally
5 scheduled substance may be scheduled higher by administrative
6 rule or to be listed in the schedules in sections 204, 206,
7 208, 210 and 212 are included by whatever official, common,
8 usual, chemical, or trade name designated.
9     (b) The Prescription Drug User Committee shall be formed in
10 order to:
11         (1) provide a uniform approach to review the Illinois
12     Controlled Substances Act in order to determine if changes
13     should be recommended to the General Assembly.
14         (2) review current drug schedules in order to manage
15     changes to the Administrative Rules pertaining to the
16     utilization of this Act.
17     (c) The User Committee will consist of:
18         (1) A representative from the Illinois Department of
19     Human Services, Bureau of Pharmacy and Clinical Support
20     Services or its successor.
21         (2) A representative from the Illinois Department of
22     Human Services, Division of Alcoholism and Substance Abuse
23     or its successor.
24         (3) A representative from the Illinois Department of
25     Financial and Professional Regulations or its successor.
26         (4) A representative from the Illinois Department of

 

 

09600HB0445sam002 - 20 - LRB096 04780 RLC 25523 a

1     Public Health.
2     (d) The Secretary of the Department of Human Services shall
3 designate the chair person of the User Committee.
4     (e) The User Committee shall meet on the first Monday on or
5 after April 1st and October 1st. Reasonable travel expenses
6 shall be paid from the Prescription Monitoring Program budget
7 line.
8 (Source: P.A. 77-757.)
 
9     (720 ILCS 570/205)  (from Ch. 56 1/2, par. 1205)
10     Sec. 205. The Department shall issue a rule scheduling a
11 substance in Schedule II if it finds that:
12     (1) the substance has high potential for abuse;
13     (2) the substance has currently accepted medical use in
14 treatment in the United States, or currently accepted medical
15 use with severe restrictions; and
16     (3) the abuse of the substance may lead to severe
17 psychological or physiological dependence; and .
18     (4) the federal scheduling agency should have assigned a
19 specific drug with a more restricted schedule.
20 (Source: P.A. 83-969.)
 
21     (720 ILCS 570/207)  (from Ch. 56 1/2, par. 1207)
22     Sec. 207. The Department shall issue a rule scheduling a
23 substance in Schedule III if it finds that:
24     (1) the substance has a potential for abuse less than the

 

 

09600HB0445sam002 - 21 - LRB096 04780 RLC 25523 a

1 substances listed in Schedule I and II;
2     (2) the substance has currently accepted medical use in
3 treatment in the United States; and
4     (3) abuse of the substance may lead to moderate or low
5 physiological dependence or high psychological dependence; and
6 .
7     (4) the federal scheduling agency should have assigned a
8 specific drug with a more restricted schedule.
9 (Source: P.A. 83-969.)
 
10     (720 ILCS 570/209)  (from Ch. 56 1/2, par. 1209)
11     Sec. 209. The Department shall issue a rule scheduling a
12 substance in Schedule IV if it finds that:
13     (1) the substance has a low potential for abuse relative to
14 substances in Schedule III;
15     (2) the substance has currently accepted medical use in
16 treatment in the United States; and
17     (3) abuse of the substance may lead to limited
18 physiological dependence or psychological dependence relative
19 to the substances in Schedule III; and .
20     (4) the federal scheduling agency should have assigned a
21 specific drug with a more restricted schedule.
22 (Source: P.A. 83-969.)
 
23     (720 ILCS 570/211)  (from Ch. 56 1/2, par. 1211)
24     Sec. 211. The Department shall issue a rule scheduling a

 

 

09600HB0445sam002 - 22 - LRB096 04780 RLC 25523 a

1 substance in Schedule V if it finds that:
2     (1) the substance has low potential for abuse relative to
3 the controlled substances listed in Schedule IV;
4     (2) the substance has currently accepted medical use in
5 treatment in the United States; and
6     (3) abuse of the substance may lead to limited
7 physiological dependence or psychological dependence relative
8 to the substances in Schedule IV, or the substance is a
9 targeted methamphetamine precursor as defined in the
10 Methamphetamine Precursor Control Act; and .
11     (4) the federal scheduling agency should have assigned a
12 specific drug with a more restricted schedule.
13 (Source: P.A. 94-694, eff. 1-15-06.)
 
14     (720 ILCS 570/214)  (from Ch. 56 1/2, par. 1214)
15     Sec. 214. Excluded Substances.
16     (a) Products containing an anabolic steroid, that are
17 expressly intended for administration through implants to
18 cattle or other nonhuman species and that have been approved by
19 the U.S. Secretary of Health and Human Services for that
20 administration, and that are excluded from all schedules under
21 Section 102(41)(B)(1) of the federal Controlled Substances Act
22 (21 U.S.C. 802(41)(B)(1)) are also excluded from Sections 207
23 and 208 of this Act.
24     (b) The non-narcotic substances excluded from all
25 schedules of the Federal Controlled Substances Act (21 U.S.C.

 

 

09600HB0445sam002 - 23 - LRB096 04780 RLC 25523 a

1 801 et seq.) pursuant to Section 1308.22 of the Code of Federal
2 Regulations (21 C.F.R. 1308.22), are excluded from all
3 schedules of this Act.
4 (Source: P.A. 91-714, eff. 6-2-00.)
 
5     (720 ILCS 570/301)  (from Ch. 56 1/2, par. 1301)
6     Sec. 301. The Department of Financial and Professional
7 Regulation shall promulgate rules and charge reasonable fees
8 and fines relating to the registration and control of the
9 manufacture, distribution, and dispensing of controlled
10 substances within this State. All moneys received by the
11 Department of Financial and Professional Regulation under this
12 Act shall be deposited into the respective professional
13 dedicated funds in like manner as the primary professional
14 licenses.
15     A pharmacy, manufacturer of controlled substances, or
16 wholesale distributor of controlled substances that is
17 regulated under this Act and owned and operated by the State is
18 exempt from fees required under this Act. Pharmacists and
19 pharmacy technicians working in facilities owned and operated
20 by the State are not exempt from the payment of fees required
21 by this Act and any rules adopted under this Act. Nothing in
22 this Section shall be construed to prohibit the Department from
23 imposing any fine or other penalty allowed under this Act.
24 (Source: P.A. 95-689, eff. 10-29-07.)
 

 

 

09600HB0445sam002 - 24 - LRB096 04780 RLC 25523 a

1     (720 ILCS 570/302)  (from Ch. 56 1/2, par. 1302)
2     Sec. 302. (a) Every person who manufactures, distributes,
3 or dispenses any controlled substances, or engages in chemical
4 analysis, and instructional activities which utilize
5 controlled substances, or who purchases, stores, or
6 administers euthanasia drugs, within this State or who proposes
7 to engage in the manufacture, distribution, or dispensing of
8 any controlled substance, or to engage in chemical analysis,
9 and instructional activities which utilize controlled
10 substances, or to engage in purchasing, storing, or
11 administering euthanasia drugs, within this State, must obtain
12 a registration issued by the Department of Financial and
13 Professional Regulation in accordance with its rules. The rules
14 shall include, but not be limited to, setting the expiration
15 date and renewal period for each registration under this Act.
16 The Department, and any facility or service licensed by the
17 Department, shall be exempt from the regulation requirements of
18 this Section.
19     (b) Persons registered by the Department of Financial and
20 Professional Regulation under this Act to manufacture,
21 distribute, or dispense controlled substances, or purchase,
22 store, or administer euthanasia drugs, may possess,
23 manufacture, distribute, or dispense those substances, or
24 purchase, store, or administer euthanasia drugs, to the extent
25 authorized by their registration and in conformity with the
26 other provisions of this Article.

 

 

09600HB0445sam002 - 25 - LRB096 04780 RLC 25523 a

1     (c) The following persons need not register and may
2 lawfully possess controlled substances under this Act:
3         (1) an agent or employee of any registered
4     manufacturer, distributor, or dispenser of any controlled
5     substance if he or she is acting in the usual course of his
6     or her employer's lawful business or employment;
7         (2) a common or contract carrier or warehouseman, or an
8     agent or employee thereof, whose possession of any
9     controlled substance is in the usual lawful course of such
10     business or employment;
11         (3) an ultimate user or a person in possession of any
12     controlled substance pursuant to a lawful prescription of a
13     practitioner or in lawful possession of a Schedule V
14     substance;
15         (4) officers and employees of this State or of the
16     United States while acting in the lawful course of their
17     official duties which requires possession of controlled
18     substances;
19         (5) a registered pharmacist who is employed in, or the
20     owner of, a pharmacy licensed under this Act and the
21     Federal Controlled Substances Act, at the licensed
22     location, or if he or she is acting in the usual course of
23     his or her lawful profession, business, or employment.
24     (d) A separate registration is required at each place of
25 business or professional practice where the applicant
26 manufactures, distributes, or dispenses controlled substances,

 

 

09600HB0445sam002 - 26 - LRB096 04780 RLC 25523 a

1 or purchases, stores, or administers euthanasia drugs. Persons
2 are required to obtain a separate registration for each place
3 of business or professional practice where controlled
4 substances are located or stored. A separate registration is
5 not required for every location at which a controlled substance
6 may be prescribed.
7     (e) The Department of Financial and Professional
8 Regulation or the Department of State Police may inspect the
9 controlled premises, as defined in Section 502 of this Act, of
10 a registrant or applicant for registration in accordance with
11 this Act and the rules promulgated hereunder and with regard to
12 persons licensed by the Department, in accordance with
13 subsection (bb) of Section 30-5 of the Alcoholism and Other
14 Drug Abuse and Dependency Act and the rules and regulations
15 promulgated thereunder.
16 (Source: P.A. 93-626, eff. 12-23-03.)
 
17     (720 ILCS 570/303)  (from Ch. 56 1/2, par. 1303)
18     Sec. 303. (a) The Department of Financial and Professional
19 Regulation shall license an applicant to manufacture,
20 distribute or dispense controlled substances included in
21 Section 202 Sections 204, 206, 208, 210 and 212 of this Act or
22 purchase, store, or administer euthanasia drugs unless it
23 determines that the issuance of that license would be
24 inconsistent with the public interest. In determining the
25 public interest, the Department of Financial and Professional

 

 

09600HB0445sam002 - 27 - LRB096 04780 RLC 25523 a

1 Regulation shall consider the following:
2         (1) maintenance of effective controls against
3     diversion of controlled substances into other than lawful
4     medical, scientific, or industrial channels;
5         (2) compliance with applicable Federal, State and
6     local law;
7         (3) any convictions of the applicant under any law of
8     the United States or of any State relating to any
9     controlled substance;
10         (4) past experience in the manufacture or distribution
11     of controlled substances, and the existence in the
12     applicant's establishment of effective controls against
13     diversion;
14         (5) furnishing by the applicant of false or fraudulent
15     material in any application filed under this Act;
16         (6) suspension or revocation of the applicant's
17     Federal registration to manufacture, distribute, or
18     dispense controlled substances, or purchase, store, or
19     administer euthanasia drugs, as authorized by Federal law;
20         (7) whether the applicant is suitably equipped with the
21     facilities appropriate to carry on the operation described
22     in his or her application;
23         (8) whether the applicant is of good moral character
24     or, if the applicant is a partnership, association,
25     corporation or other organization, whether the partners,
26     directors, governing committee and managing officers are

 

 

09600HB0445sam002 - 28 - LRB096 04780 RLC 25523 a

1     of good moral character;
2         (9) any other factors relevant to and consistent with
3     the public health and safety; and
4         (10) evidence from court, medical disciplinary and
5     pharmacy board records and those of State and Federal
6     investigatory bodies that the applicant has not or does not
7     prescribe controlled substances within the provisions of
8     this Act.
9     (b) No license shall be granted to or renewed for any
10 person who has within 5 years been convicted of a willful
11 wilful violation of any law of the United States or any law of
12 any State relating to controlled substances, or who is found to
13 be deficient in any of the matters enumerated in subsections
14 (a)(1) through (a)(8).
15     (c) Licensure under subsection (a) does not entitle a
16 registrant to manufacture, distribute or dispense controlled
17 substances in Schedules I or II other than those specified in
18 the registration.
19     (d) Practitioners who are licensed to dispense any
20 controlled substances in Schedules II through V are authorized
21 to conduct instructional activities with controlled substances
22 in Schedules II through V under the law of this State.
23     (e) If an applicant for registration is registered under
24 the Federal law to manufacture, distribute or dispense
25 controlled substances, or purchase, store, or administer
26 euthanasia drugs, upon filing a completed application for

 

 

09600HB0445sam002 - 29 - LRB096 04780 RLC 25523 a

1 licensure in this State and payment of all fees due hereunder,
2 he or she shall be licensed in this State to the same extent as
3 his or her Federal registration, unless, within 30 days after
4 completing his or her application in this State, the Department
5 of Financial and Professional Regulation notifies the
6 applicant that his or her application has not been granted. A
7 practitioner who is in compliance with the Federal law with
8 respect to registration to dispense controlled substances in
9 Schedules II through V need only send a current copy of that
10 Federal registration to the Department of Financial and
11 Professional Regulation and he or she shall be deemed in
12 compliance with the registration provisions of this State.
13     (e-5) Beginning July 1, 2003, all of the fees and fines
14 collected under this Section 303 shall be deposited into the
15 Illinois State Pharmacy Disciplinary Fund.
16     (f) The fee for registration as a manufacturer or wholesale
17 distributor of controlled substances shall be $50.00 per year,
18 except that the fee for registration as a manufacturer or
19 wholesale distributor of controlled substances that may be
20 dispensed without a prescription under this Act shall be $15.00
21 per year. The expiration date and renewal period for each
22 controlled substance license issued under this Act shall be set
23 by rule.
24 (Source: P.A. 93-32, eff. 7-1-03; 93-626, eff. 12-23-03.)
 
25     (720 ILCS 570/303.05)

 

 

09600HB0445sam002 - 30 - LRB096 04780 RLC 25523 a

1     Sec. 303.05. Mid-level practitioner registration.
2     (a) The Department of Financial and Professional
3 Regulation shall register licensed physician assistants and
4 licensed advanced practice nurses to prescribe and dispense
5 Schedule III, IV, or V controlled substances under Section 303
6 and euthanasia agencies to purchase, store, or administer
7 euthanasia drugs under the following circumstances:
8         (1) with respect to physician assistants or advanced
9     practice nurses,
10             (A) the physician assistant or advanced practice
11         nurse has been delegated prescriptive authority by a
12         physician licensed to practice medicine in all its
13         branches in accordance with Section 7.5 of the
14         Physician Assistant Practice Act of 1987 or Section
15         65-40 of the Nurse Practice Act; and
16             (B) the physician assistant or advanced practice
17         nurse has completed the appropriate application forms
18         and has paid the required fees as set by rule; or
19         (2) with respect to euthanasia agencies, the
20     euthanasia agency has obtained a license from the
21     Department of Financial and Professional Regulation and
22     obtained a registration number from the Department.
23     (b) The mid-level practitioner shall only be licensed to
24 prescribe those schedules of controlled substances for which a
25 licensed physician has delegated prescriptive authority,
26 except that a euthanasia agency does not have any prescriptive

 

 

09600HB0445sam002 - 31 - LRB096 04780 RLC 25523 a

1 authority.
2     (c) Upon completion of all registration requirements,
3 physician assistants, advanced practice nurses, and euthanasia
4 agencies shall be issued a mid-level practitioner controlled
5 substances license for Illinois.
6 (Source: P.A. 95-639, eff. 10-5-07.)
 
7     (720 ILCS 570/303.1)  (from Ch. 56 1/2, par. 1303.1)
8     Sec. 303.1. Any person who delivers a check or other
9 payment to the Department of Financial and Professional
10 Regulation that is returned to the Department of Financial and
11 Professional Regulation unpaid by the financial institution
12 upon which it is drawn shall pay to the Department of Financial
13 and Professional Regulation, in addition to the amount already
14 owed to the Department of Financial and Professional
15 Regulation, a fine of $50. If the check or other payment was
16 for a renewal or issuance fee and that person practices without
17 paying the renewal fee or issuance fee and the fine due, an
18 additional fine of $100 shall be imposed. The fines imposed by
19 this Section are in addition to any other discipline provided
20 under this Act for unlicensed practice or practice on a
21 nonrenewed license. The Department of Financial and
22 Professional Regulation shall notify the person that payment of
23 fees and fines shall be paid to the Department of Financial and
24 Professional Regulation by certified check or money order
25 within 30 calendar days of the notification. If, after the

 

 

09600HB0445sam002 - 32 - LRB096 04780 RLC 25523 a

1 expiration of 30 days from the date of the notification, the
2 person has failed to submit the necessary remittance, the
3 Department of Financial and Professional Regulation shall
4 automatically terminate the license or certificate or deny the
5 application, without hearing. If, after termination or denial,
6 the person seeks a license or certificate, he or she shall
7 apply to the Department of Financial and Professional
8 Regulation for restoration or issuance of the license or
9 certificate and pay all fees and fines due to the Department of
10 Financial and Professional Regulation. The Department of
11 Financial and Professional Regulation may establish a fee for
12 the processing of an application for restoration of a license
13 or certificate to pay all expenses of processing this
14 application. The Secretary of Financial and Professional
15 Regulation Director may waive the fines due under this Section
16 in individual cases where the Secretary of Financial and
17 Professional Regulation Director finds that the fines would be
18 unreasonable or unnecessarily burdensome.
19 (Source: P.A. 89-507, eff. 7-1-97.)
 
20     (720 ILCS 570/304)  (from Ch. 56 1/2, par. 1304)
21     Sec. 304. (a) A registration under Section 303 to
22 manufacture, distribute, or dispense a controlled substance or
23 purchase, store, or administer euthanasia drugs may be
24 suspended or revoked by the Department of Financial and
25 Professional Regulation upon a finding that the registrant:

 

 

09600HB0445sam002 - 33 - LRB096 04780 RLC 25523 a

1         (1) has furnished any false or fraudulent material
2     information in any application filed under this Act; or
3         (2) has been convicted of a felony under any law of the
4     United States or any State relating to any controlled
5     substance; or
6         (3) has had suspended or revoked his or her Federal
7     registration to manufacture, distribute, or dispense
8     controlled substances or purchase, store, or administer
9     euthanasia drugs; or
10         (4) has been convicted of bribery, perjury, or other
11     infamous crime under the laws of the United States or of
12     any State; or
13         (5) has violated any provision of this Act or any rules
14     promulgated hereunder, or any provision of the
15     Methamphetamine Precursor Control Act or rules promulgated
16     thereunder, whether or not he or she has been convicted of
17     such violation; or
18         (6) has failed to provide effective controls against
19     the diversion of controlled substances in other than
20     legitimate medical, scientific or industrial channels.
21     (b) The Department of Financial and Professional
22 Regulation may limit revocation or suspension of a registration
23 to the particular controlled substance with respect to which
24 grounds for revocation or suspension exist.
25     (c) The Department of Financial and Professional
26 Regulation shall promptly notify the Administration, the

 

 

09600HB0445sam002 - 34 - LRB096 04780 RLC 25523 a

1 Department of Human Services and the Department of State Police
2 or their successor agencies, of all orders denying, suspending
3 or revoking registration, all forfeitures of controlled
4 substances, and all final court dispositions, if any, of such
5 denials, suspensions, revocations or forfeitures.
6     (d) If Federal registration of any registrant is suspended,
7 revoked, refused renewal or refused issuance, then the
8 Department of Financial and Professional Regulation shall
9 issue a notice and conduct a hearing in accordance with Section
10 305 of this Act.
11 (Source: P.A. 93-626, eff. 12-23-03; 94-694, eff. 1-15-06.)
 
12     (720 ILCS 570/305)  (from Ch. 56 1/2, par. 1305)
13     Sec. 305. (a) Before denying, refusing renewal of,
14 suspending or revoking a registration, the Department of
15 Financial and Professional Regulation shall serve upon the
16 applicant or registrant, by registered mail at the address in
17 the application or registration or by any other means
18 authorized under the Civil Practice Law or Rules of the
19 Illinois Supreme Court for the service of summons or subpoenas,
20 a notice of hearing to determine why registration should not be
21 denied, refused renewal, suspended or revoked. The notice shall
22 contain a statement of the basis therefor and shall call upon
23 the applicant or registrant to appear before the Department of
24 Financial and Professional Regulation at a reasonable time and
25 place. These proceedings shall be conducted in accordance with

 

 

09600HB0445sam002 - 35 - LRB096 04780 RLC 25523 a

1 Sections 2105-5, 2105-15, 2105-100, 2105-105, 2105-110,
2 2105-115, 2105-120, 2105-125, 2105-175, and 2105-325 of the
3 Department of Financial and Professional Regulation Law (20
4 ILCS 2105/2105-5, 2105/2105-15, 2105/2105-100, 2105/2105-105,
5 2105/2105-110, 2105/2105-115, 2105/2105-120, 2105/2105-125,
6 2105/2105-175, and 2105/2105-325), without regard to any
7 criminal prosecution or other proceeding. Except as authorized
8 in subsection (c), proceedings to refuse renewal or suspend or
9 revoke registration shall not abate the existing registration,
10 which shall remain in effect until the Department of Financial
11 and Professional Regulation has held the hearing called for in
12 the notice and found, with input from the appropriate licensure
13 or disciplinary board, that the registration shall no longer
14 remain in effect.
15     (b) The Secretary of the Department of Financial and
16 Professional Regulation Director may appoint an attorney duly
17 licensed to practice law in the State of Illinois to serve as
18 the hearing officer in any action to deny, refuse to renew,
19 suspend, or revoke, or take any other disciplinary action with
20 regard to a registration. The hearing officer shall have full
21 authority to conduct the hearing. The hearing officer shall
22 report his or her findings and recommendations to the
23 appropriate licensure or disciplinary board within 30 days
24 after receiving the record. The Disciplinary Board shall have
25 60 days from receipt of the report to review the report of the
26 hearing officer and present its findings of fact, conclusions

 

 

09600HB0445sam002 - 36 - LRB096 04780 RLC 25523 a

1 of law, and recommendations to the Secretary of the Department
2 of Financial and Professional Regulation Director.
3     (c) If the Department of Financial and Professional
4 Regulation finds that there is an imminent danger to the public
5 health or safety by the continued manufacture, distribution or
6 dispensing of controlled substances by the registrant, the
7 Department of Financial and Professional Regulation may, upon
8 the issuance of a written ruling stating the reasons for such
9 finding and without notice or hearing, suspend such registrant.
10 The suspension shall continue in effect for not more than 14
11 days during which time the registrant shall be given a hearing
12 on the issues involved in the suspension. If after the hearing,
13 and after input from the appropriate licensure or disciplinary
14 board, the Department of Financial and Professional Regulation
15 finds that the public health or safety requires the suspension
16 to remain in effect it shall so remain until the ruling is
17 terminated by its own terms or subsequent ruling or is
18 dissolved by a circuit court upon determination that the
19 suspension was wholly without basis in fact and law.
20     (d) If, after a hearing as provided in subsection (a), the
21 Department of Financial and Professional Regulation finds that
22 a registration should be refused renewal, suspended or revoked,
23 a written ruling to that effect shall be entered. The
24 Department of Financial and Professional Regulation's ruling
25 shall remain in effect until the ruling is terminated by its
26 own terms or subsequent ruling or is dissolved by a circuit

 

 

09600HB0445sam002 - 37 - LRB096 04780 RLC 25523 a

1 court upon a determination that the refusal to renew suspension
2 or revocation was wholly without basis in fact and law.
3 (Source: P.A. 91-239, eff. 1-1-00.)
 
4     (720 ILCS 570/306)  (from Ch. 56 1/2, par. 1306)
5     Sec. 306. Every practitioner and person who is required
6 under this Act to be registered to manufacture, distribute or
7 dispense controlled substances or purchase, store, or
8 administer euthanasia drugs under this Act shall keep records
9 and maintain inventories in conformance with the recordkeeping
10 and inventory requirements of the laws of the United States and
11 with any additional rules and forms issued by the Department of
12 Financial and Professional Regulation.
13 (Source: P.A. 93-626, eff. 12-23-03.)
 
14     (720 ILCS 570/309)  (from Ch. 56 1/2, par. 1309)
15     Sec. 309. On or after April 1, 2000, no person shall issue
16 a prescription for a Schedule II controlled substance, which is
17 a narcotic drug listed in Section 202 206 of this Act; or which
18 contains any quantity of amphetamine or methamphetamine, their
19 salts, optical isomers or salts of optical isomers;
20 phenmetrazine and its salts; gluthethimide; and pentazocine,
21 other than on a written prescription; provided that in the case
22 of an emergency, epidemic or a sudden or unforeseen accident or
23 calamity, the prescriber may issue a lawful oral prescription
24 where failure to issue such a prescription might result in loss

 

 

09600HB0445sam002 - 38 - LRB096 04780 RLC 25523 a

1 of life or intense suffering, but such oral prescription shall
2 include a statement by the prescriber concerning the accident
3 or calamity, or circumstances constituting the emergency, the
4 cause for which an oral prescription was used. Within 7 days
5 after issuing an emergency prescription, the prescriber shall
6 cause a written prescription for the emergency quantity
7 prescribed to be delivered to the dispensing pharmacist. The
8 prescription shall have written on its face "Authorization for
9 Emergency Dispensing", and the date of the emergency
10 prescription. The written prescription may be delivered to the
11 pharmacist in person, or by mail, but if delivered by mail it
12 must be postmarked within the 7-day period. Upon receipt, the
13 dispensing pharmacist shall attach this prescription to the
14 emergency oral prescription earlier received and reduced to
15 writing. The dispensing pharmacist shall notify the Department
16 of Financial and Professional Regulation Human Services if the
17 prescriber fails to deliver the authorization for emergency
18 dispensing on the prescription to him or her. Failure of the
19 dispensing pharmacist to do so shall void the authority
20 conferred by this paragraph to dispense without a written
21 prescription of a prescriber. All prescriptions issued for
22 Schedule II controlled substances shall include both a written
23 and numerical notation of quantity on the face of the
24 prescription. No prescription for a Schedule II controlled
25 substance may be refilled. The Department shall provide, at no
26 cost, audit reviews and necessary information to the Department

 

 

09600HB0445sam002 - 39 - LRB096 04780 RLC 25523 a

1 of Financial and Professional Regulation in conjunction with
2 ongoing investigations being conducted in whole or part by the
3 Department of Financial and Professional Regulation.
4 (Source: P.A. 95-689, eff. 10-29-07.)
 
5     (720 ILCS 570/312)  (from Ch. 56 1/2, par. 1312)
6     Sec. 312. Requirements for dispensing controlled
7 substances.
8     (a) A practitioner, in good faith, may dispense a Schedule
9 II controlled substance, which is a narcotic drug listed in
10 Section 202 206 of this Act, ; or which contains any quantity
11 of amphetamine or methamphetamine, their salts, optical
12 isomers or salts of optical isomers; phenmetrazine and its
13 salts; or pentazocine; and Schedule III, IV, or V controlled
14 substances to any person upon a written prescription of any
15 prescriber, dated and signed by the person prescribing on the
16 day when issued and bearing the name and address of the patient
17 for whom, or the owner of the animal for which the controlled
18 substance is dispensed, and the full name, address and registry
19 number under the laws of the United States relating to
20 controlled substances of the prescriber, if he or she is
21 required by those laws to be registered. If the prescription is
22 for an animal it shall state the species of animal for which it
23 is ordered. The practitioner filling the prescription shall,
24 unless otherwise allowed, write the date of filling and his or
25 her own signature on the face of the written prescription. The

 

 

09600HB0445sam002 - 40 - LRB096 04780 RLC 25523 a

1 written prescription shall be retained on file by the
2 practitioner who filled it or pharmacy in which the
3 prescription was filled for a period of 2 years, so as to be
4 readily accessible for inspection or removal by any officer or
5 employee engaged in the enforcement of this Act. Whenever the
6 practitioner's or pharmacy's copy of any prescription is
7 removed by an officer or employee engaged in the enforcement of
8 this Act, for the purpose of investigation or as evidence, such
9 officer or employee shall give to the practitioner or pharmacy
10 a receipt in lieu thereof. A Schedule II prescription may be
11 issued for one 30 day period. A second and third, 30 day
12 prescription for the same medication may be entered by the
13 prescriber on the same prescription blank or form. The
14 dispenser may, for insurance or other reimbursement purposes
15 enter the prescription as a 90 day supply, but the dispenser
16 may only partial fill up to a maximum of a 30 day supply at a
17 time. The prescriber or dispenser may further limit the
18 quantity dispensed based upon the medical condition of the
19 patient. The dispenser is not prohibited from charging a
20 dispensing fee for each instance in which medication is
21 dispensed under a single prescription as described above. If
22 the specific prescription is machine or computer generated at
23 the prescriber's office, the date does not need to be
24 handwritten. A prescription for a Schedule II controlled
25 substance shall not be filled more than 7 days after the date
26 of issuance. A written prescription for Schedule III, IV or V

 

 

09600HB0445sam002 - 41 - LRB096 04780 RLC 25523 a

1 controlled substances shall not be filled or refilled more than
2 6 months after the date thereof or refilled more than 5 times
3 unless renewed, in writing, by the prescriber.
4     (b) In lieu of a written prescription required by this
5 Section, a pharmacist, in good faith, may dispense Schedule
6 III, IV, or V substances to any person either upon receiving a
7 facsimile of a written, signed prescription transmitted by the
8 prescriber or the prescriber's agent or upon a lawful oral
9 prescription of a prescriber which oral prescription shall be
10 reduced promptly to writing by the pharmacist and such written
11 memorandum thereof shall be dated on the day when such oral
12 prescription is received by the pharmacist and shall bear the
13 full name and address of the ultimate user for whom, or of the
14 owner of the animal for which the controlled substance is
15 dispensed, and the full name, address, and registry number
16 under the law of the United States relating to controlled
17 substances of the prescriber prescribing if he or she is
18 required by those laws to be so registered, and the pharmacist
19 filling such oral prescription shall write the date of filling
20 and his or her own signature on the face of such written
21 memorandum thereof. The facsimile copy of the prescription or
22 written memorandum of the oral prescription shall be retained
23 on file by the proprietor of the pharmacy in which it is filled
24 for a period of not less than two years, so as to be readily
25 accessible for inspection by any officer or employee engaged in
26 the enforcement of this Act in the same manner as a written

 

 

09600HB0445sam002 - 42 - LRB096 04780 RLC 25523 a

1 prescription. The facsimile copy of the prescription or oral
2 prescription and the written memorandum thereof shall not be
3 filled or refilled more than 6 months after the date thereof or
4 be refilled more than 5 times, unless renewed, in writing, by
5 the prescriber.
6     (c) Except for any non-prescription targeted
7 methamphetamine precursor regulated by the Methamphetamine
8 Precursor Control Act, a controlled substance included in
9 Schedule V shall not be distributed or dispensed other than for
10 a medical purpose and not for the purpose of evading this Act,
11 and then:
12         (1) only personally by a person registered to dispense
13     a Schedule V controlled substance and then only to his or
14     her patients, or
15         (2) only personally by a pharmacist, and then only to a
16     person over 21 years of age who has identified himself or
17     herself to the pharmacist by means of 2 positive documents
18     of identification.
19         (3) the dispenser shall record the name and address of
20     the purchaser, the name and quantity of the product, the
21     date and time of the sale, and the dispenser's signature.
22         (4) no person shall purchase or be dispensed more than
23     120 milliliters or more than 120 grams of any Schedule V
24     substance which contains codeine, dihydrocodeine, or any
25     salts thereof, or ethylmorphine, or any salts thereof, in
26     any 96 hour period. The purchaser shall sign a form,

 

 

09600HB0445sam002 - 43 - LRB096 04780 RLC 25523 a

1     approved by the Department of Financial and Professional
2     Regulation, attesting that he or she has not purchased any
3     Schedule V controlled substances within the immediately
4     preceding 96 hours.
5         (5) (Blank). a copy of the records of sale, including
6     all information required by paragraph (3), shall be
7     forwarded to the Department of Professional Regulation at
8     its principal office by the 15th day of the following
9     month.
10         (6) all records of purchases and sales shall be
11     maintained for not less than 2 years.
12         (7) no person shall obtain or attempt to obtain within
13     any consecutive 96 hour period any Schedule V substances of
14     more than 120 milliliters or more than 120 grams containing
15     codeine, dihydrocodeine or any of its salts, or
16     ethylmorphine or any of its salts. Any person obtaining any
17     such preparations or combination of preparations in excess
18     of this limitation shall be in unlawful possession of such
19     controlled substance.
20         (8) a person qualified to dispense controlled
21     substances under this Act and registered thereunder shall
22     at no time maintain or keep in stock a quantity of Schedule
23     V controlled substances defined and listed in Section 212
24     (b) (1), (2) or (3) in excess of 4.5 liters for each
25     substance; a pharmacy shall at no time maintain or keep in
26     stock a quantity of Schedule V controlled substances as

 

 

09600HB0445sam002 - 44 - LRB096 04780 RLC 25523 a

1     defined in excess of 4.5 liters for each substance, plus
2     the additional quantity of controlled substances necessary
3     to fill the largest number of prescription orders filled by
4     that pharmacy for such controlled substances in any one
5     week in the previous year. These limitations shall not
6     apply to Schedule V controlled substances which Federal law
7     prohibits from being dispensed without a prescription.
8         (9) no person shall distribute or dispense butyl
9     nitrite for inhalation or other introduction into the human
10     body for euphoric or physical effect.
11     (d) Every practitioner shall keep a record of controlled
12 substances received by him or her and a record of all such
13 controlled substances administered, dispensed or
14 professionally used by him or her otherwise than by
15 prescription. It shall, however, be sufficient compliance with
16 this paragraph if any practitioner utilizing controlled
17 substances listed in Schedules III, IV and V shall keep a
18 record of all those substances dispensed and distributed by him
19 or her other than those controlled substances which are
20 administered by the direct application of a controlled
21 substance, whether by injection, inhalation, ingestion, or any
22 other means to the body of a patient or research subject. A
23 practitioner who dispenses, other than by administering, a
24 Schedule II controlled substance in Schedule II, which is a
25 narcotic drug listed in Section 206 of this Act, or which
26 contains any quantity of amphetamine or methamphetamine, their

 

 

09600HB0445sam002 - 45 - LRB096 04780 RLC 25523 a

1 salts, optical isomers or salts of optical isomers,
2 pentazocine, or methaqualone shall do so only upon the issuance
3 of a written prescription blank by a prescriber.
4     (e) Whenever a manufacturer distributes a controlled
5 substance in a package prepared by him or her, and whenever a
6 wholesale distributor distributes a controlled substance in a
7 package prepared by him or her or the manufacturer, he or she
8 shall securely affix to each package in which that substance is
9 contained a label showing in legible English the name and
10 address of the manufacturer, the distributor and the quantity,
11 kind and form of controlled substance contained therein. No
12 person except a pharmacist and only for the purposes of filling
13 a prescription under this Act, shall alter, deface or remove
14 any label so affixed.
15     (f) Whenever a practitioner dispenses any controlled
16 substance except a non-prescription targeted methamphetamine
17 precursor regulated by the Methamphetamine Precursor Control
18 Act, he or she shall affix to the container in which such
19 substance is sold or dispensed, a label indicating the date of
20 initial filling, the practitioner's name and address, the name
21 of the patient, the name of the prescriber, the directions for
22 use and cautionary statements, if any, contained in any
23 prescription or required by law, the proprietary name or names
24 or the established name of the controlled substance, and the
25 dosage and quantity, except as otherwise authorized by
26 regulation by the Department of Financial and Professional

 

 

09600HB0445sam002 - 46 - LRB096 04780 RLC 25523 a

1 Regulation. No person shall alter, deface or remove any label
2 so affixed as long as any of the specific medication remains in
3 the container.
4     (g) A person to whom or for whose use any controlled
5 substance has been prescribed or dispensed by a practitioner,
6 or other persons authorized under this Act, and the owner of
7 any animal for which such substance has been prescribed or
8 dispensed by a veterinarian, may lawfully possess such
9 substance only in the container in which it was delivered to
10 him or her by the person dispensing such substance.
11     (h) The responsibility for the proper prescribing or
12 dispensing of controlled substances that are under the
13 prescriber's direct control is upon the prescriber. The and the
14 responsibility for the proper filling of a prescription for
15 controlled substance drugs rests with the pharmacist. An order
16 purporting to be a prescription issued to any individual, which
17 is not in the regular course of professional treatment nor part
18 of an authorized methadone maintenance program, nor in
19 legitimate and authorized research instituted by any
20 accredited hospital, educational institution, charitable
21 foundation, or federal, state or local governmental agency, and
22 which is intended to provide that individual with controlled
23 substances sufficient to maintain that individual's or any
24 other individual's physical or psychological addiction,
25 habitual or customary use, dependence, or diversion of that
26 controlled substance is not a prescription within the meaning

 

 

09600HB0445sam002 - 47 - LRB096 04780 RLC 25523 a

1 and intent of this Act; and the person issuing it, shall be
2 subject to the penalties provided for violations of the law
3 relating to controlled substances.
4     (i) A prescriber shall not preprint or cause to be
5 preprinted a prescription for any controlled substance; nor
6 shall any practitioner issue, fill or cause to be issued or
7 filled, a preprinted prescription for any controlled
8 substance. In order to avoid handwriting errors a prescriber
9 may use a machine or computer type device to individually
10 generate a printed prescription or electronically transmit a
11 prescription to a dispenser of the patient's choice; however,
12 the prescriber is still required to affix his or her original
13 or approved, secure electronic signature to the prescription.
14     (j) No person shall manufacture, dispense, deliver,
15 possess with intent to deliver, prescribe, or administer or
16 cause to be administered under his or her direction any
17 anabolic steroid, for any use in humans other than the
18 treatment of disease in accordance with the order of a
19 physician licensed to practice medicine in all its branches for
20 a valid medical purpose in the course of professional practice.
21 The use of anabolic steroids for the purpose of hormonal
22 manipulation that is intended to increase muscle mass, strength
23 or weight without a medical necessity to do so, or for the
24 intended purpose of improving physical appearance or
25 performance in any form of exercise, sport, or game, is not a
26 valid medical purpose or in the course of professional

 

 

09600HB0445sam002 - 48 - LRB096 04780 RLC 25523 a

1 practice.
2     (k) As allowed by the federal electronic signature statute
3 or administrative rule, a prescriber may establish with any
4 dispenser an approved, secure electronic signature, which
5 shall have the effect of an original signature for any
6 prescription.
7     (l) If an electronic signature authorization is
8 established between a prescriber and a dispenser, the
9 prescriber may electronically transmit a prescription on a
10 secure connection between the prescriber and the dispenser.
11     (m) An electronically presented prescription may only be
12 used with established patients.
13     (n) A prescriber's first-time patient may only use a
14 prescription prepared in the prescriber's office.
15     (o) In the case of a prescription for a Schedule II
16 medication which has an electronic signature of the prescriber,
17 the dispenser must confirm the prescription by means of
18 telephone or facsimile or other one-to-one contact with the
19 prescriber. The dispenser must note the name of the individual
20 contacted and the date and time on the prescription.
21     (p) Failure to comply with the law regarding the electronic
22 signature or the electronically presented prescription shall
23 be considered a deceptive practice.
24 (Source: P.A. 94-694, eff. 1-15-06; 94-830, eff. 6-5-06.)
 
25     (720 ILCS 570/313)  (from Ch. 56 1/2, par. 1313)

 

 

09600HB0445sam002 - 49 - LRB096 04780 RLC 25523 a

1     Sec. 313. (a) Controlled substances which are lawfully
2 administered in hospitals or institutions licensed under the
3 "Hospital Licensing Act" shall be exempt from the requirements
4 of Sections 312 and 316 except that the prescription for the
5 controlled substance shall be in writing on the patient's
6 record, signed by the prescriber, dated, and shall state the
7 name, and quantity of controlled substances ordered and the
8 quantity actually administered. The records of such
9 prescriptions shall be maintained for two years and shall be
10 available for inspection by officers and employees of the
11 Department of State Police, and the Department of Financial and
12 Professional Regulation.
13     (b) Controlled substances that can lawfully be
14 administered or dispensed directly to a patient in a long-term
15 care facility licensed by the Department of Public Health as a
16 skilled nursing facility, intermediate care facility, or
17 long-term care facility for residents under 22 years of age,
18 are exempt from the requirements of Section 312 except that a
19 prescription for a Schedule II controlled substance must be
20 either a written prescription signed by the prescriber or a
21 written prescription transmitted by the prescriber or
22 prescriber's agent to the dispensing pharmacy by facsimile. The
23 facsimile serves as the original prescription and must be
24 maintained for 2 years from the date of issue in the same
25 manner as a written prescription signed by the prescriber.
26     (c) A prescription that is originated written for a

 

 

09600HB0445sam002 - 50 - LRB096 04780 RLC 25523 a

1 Schedule II controlled substance to be compounded for direct
2 administration by parenteral, intravenous, intramuscular,
3 subcutaneous, or intraspinal infusion to a patient in a private
4 residence, long-term care facility, or hospice program may be
5 transmitted by facsimile by the prescriber or the prescriber's
6 agent to the pharmacy providing the home infusion services. The
7 facsimile serves as the original written prescription for
8 purposes of this paragraph (c) and it shall be maintained in
9 the same manner as the original written prescription.
10     (c-1) A prescription generated written for a Schedule II
11 controlled substance for a patient residing in a hospice
12 certified by Medicare under Title XVIII of the Social Security
13 Act or licensed by the State may be transmitted by the
14 practitioner or the practitioner's agent to the dispensing
15 pharmacy by facsimile. The practitioner or practitioner's
16 agent must note on the prescription that the patient is a
17 hospice patient. The facsimile serves as the original written
18 prescription for purposes of this paragraph (c-1) and it shall
19 be maintained in the same manner as the original written
20 prescription.
21     (d) Controlled substances which are lawfully administered
22 and/or dispensed in drug abuse treatment programs licensed by
23 the Department shall be exempt from the requirements of
24 Sections 312 and 316, except that the prescription for such
25 controlled substances shall be issued and authenticated on
26 official prescription logs prepared and supplied by the

 

 

09600HB0445sam002 - 51 - LRB096 04780 RLC 25523 a

1 Department. The official prescription logs issued by the
2 Department shall be printed in triplicate on distinctively
3 marked paper and furnished to programs at reasonable cost. The
4 official prescription logs furnished to the programs shall
5 contain, in preprinted form, such information as the Department
6 may require. The official prescription logs shall be properly
7 endorsed by a physician licensed to practice medicine in all
8 its branches issuing the order, with his or her own signature
9 and the date of ordering, and further endorsed by the
10 practitioner actually administering or dispensing the dosage
11 at the time of such administering or dispensing in accordance
12 with requirements issued by the Department. The duplicate copy
13 shall be retained by the program for a period of not less than
14 three years nor more than seven years; the original and
15 triplicate copy shall be returned to the Department at its
16 principal office in accordance with requirements set forth by
17 the Department.
18 (Source: P.A. 95-442, eff. 1-1-08.)
 
19     (720 ILCS 570/318)
20     Sec. 318. Confidentiality of information.
21     (a) Information received by the central repository under
22 Section 316 and 321 is confidential.
23     (b) The Department must carry out a program to protect the
24 confidentiality of the information described in subsection
25 (a). The Department may disclose the information to another

 

 

09600HB0445sam002 - 52 - LRB096 04780 RLC 25523 a

1 person only under subsection (c), (d), or (f) and may charge a
2 fee not to exceed the actual cost of furnishing the
3 information.
4     (c) The Department may disclose confidential information
5 described in subsection (a) to any person who is engaged in
6 receiving, processing, or storing the information.
7     (d) The Department may release confidential information
8 described in subsection (a) to the following persons:
9         (1) A governing body that licenses practitioners and is
10     engaged in an investigation, an adjudication, or a
11     prosecution of a violation under any State or federal law
12     that involves a controlled substance.
13         (2) An investigator for the Consumer Protection
14     Division of the office of the Attorney General, a
15     prosecuting attorney, the Attorney General, a deputy
16     Attorney General, or an investigator from the office of the
17     Attorney General, who is engaged in any of the following
18     activities involving controlled substances:
19             (A) an investigation;
20             (B) an adjudication; or
21             (C) a prosecution of a violation under any State or
22         federal law that involves a controlled substance.
23         (3) A law enforcement officer who is:
24             (A) authorized by the Department of State Police or
25         the office of a county sheriff or State's Attorney or
26         municipal police department of Illinois to receive

 

 

09600HB0445sam002 - 53 - LRB096 04780 RLC 25523 a

1         information of the type requested for the purpose of
2         investigations involving controlled substances; or
3             (B) approved by the Department to receive
4         information of the type requested for the purpose of
5         investigations involving controlled substances; and
6             (C) engaged in the investigation or prosecution of
7         a violation under any State or federal law that
8         involves a controlled substance.
9     (e) Before the Department releases confidential
10 information under subsection (d), the applicant must
11 demonstrate in writing to the Department that:
12         (1) the applicant has reason to believe that a
13     violation under any State or federal law that involves a
14     controlled substance has occurred; and
15         (2) the requested information is reasonably related to
16     the investigation, adjudication, or prosecution of the
17     violation described in subdivision (1).
18     (f) The Department may receive and release prescription
19 record information to:
20         (1) a governing body that licenses practitioners;
21         (2) an investigator for the Consumer Protection
22     Division of the office of the Attorney General, a
23     prosecuting attorney, the Attorney General, a deputy
24     Attorney General, or an investigator from the office of the
25     Attorney General;
26         (3) any Illinois law enforcement officer who is:

 

 

09600HB0445sam002 - 54 - LRB096 04780 RLC 25523 a

1             (A) authorized to receive the type of information
2         released; and
3             (B) approved by the Department to receive the type
4         of information released; or
5         (4) prescription monitoring entities in other states
6     per the provisions outlined in subsection (g) and (h)
7     below;
8 confidential prescription record information collected under
9 Sections 316 and 321 that identifies vendors or practitioners,
10 or both, who are prescribing or dispensing large quantities of
11 Schedule II, III, IV, or V controlled substances outside the
12 scope of their practice, pharmacy, or business, as determined
13 by the Advisory Committee created by Section 320.
14     (g) The information described in subsection (f) may not be
15 released until it has been reviewed by an employee of the
16 Department who is licensed as a prescriber or a dispenser and
17 until that employee has certified that further investigation is
18 warranted. However, failure to comply with this subsection (g)
19 does not invalidate the use of any evidence that is otherwise
20 admissible in a proceeding described in subsection (h).
21     (h) An investigator or a law enforcement officer receiving
22 confidential information under subsection (c), (d), or (f) may
23 disclose the information to a law enforcement officer or an
24 attorney for the office of the Attorney General for use as
25 evidence in the following:
26         (1) A proceeding under any State or federal law that

 

 

09600HB0445sam002 - 55 - LRB096 04780 RLC 25523 a

1     involves a controlled substance.
2         (2) A criminal proceeding or a proceeding in juvenile
3     court that involves a controlled substance.
4     (i) The Department may compile statistical reports from the
5 information described in subsection (a). The reports must not
6 include information that identifies, by name, license or
7 address, any practitioner, dispenser, ultimate user, or other
8 person administering a controlled substance.
9     (j) Based upon federal, initial and maintenance funding, a
10 prescriber and dispenser inquiry system shall be developed to
11 assist the medical community in its goal of effective clinical
12 practice and to prevent patients from diverting or abusing
13 medications.
14         (1) An inquirer shall have read-only access to a
15     stand-alone database which shall contain records for the
16     previous 6 months.
17         (2) Dispensers may, upon positive and secure
18     identification, make an inquiry on a patient or customer
19     solely for a medical purpose as delineated within the
20     federal HIPAA law.
21         (3) The Department shall provide a one-to-one secure
22     link and encrypted software necessary to establish the link
23     between an inquirer and the Department. Technical
24     assistance shall also be provided.
25         (4) Written inquiries are acceptable but must include
26     the fee and the requestor's Drug Enforcement

 

 

09600HB0445sam002 - 56 - LRB096 04780 RLC 25523 a

1     Administration license number and submitted upon the
2     requestor's business stationary.
3         (5) No data shall be stored in the database beyond 24
4     months.
5         (6) Tracking analysis shall be established and used per
6     administrative rule.
7         (7) Nothing in this Act or Illinois law shall be
8     construed to require a prescriber or dispenser to make use
9     of this inquiry system.
10         (8) If there is an adverse outcome because of a
11     prescriber or dispenser making an inquiry, which is
12     initiated in good faith, the prescriber or dispenser shall
13     be held harmless from any civil liability.
14     (k) Based upon federal and initial and maintenance funding,
15 unless appropriated or otherwise authorized by the General
16 Assembly, a restricted and secure inquiry system shall be
17 developed to assist the law enforcement community in its goal
18 to enforce federal and State law as well as local ordinances
19 related to prescription medications. Criteria for the inquiry
20 system shall follow the criteria provided in subsection (j)
21 noted above, except that the records shall be for the previous
22 24 months and with the addition that any person making an
23 inquiry must attest that said inquiry is strictly for the
24 purpose of conducting a probable cause investigation only.
25 (Source: P.A. 95-442, eff. 1-1-08.)
 

 

 

09600HB0445sam002 - 57 - LRB096 04780 RLC 25523 a

1     (720 ILCS 570/405)  (from Ch. 56 1/2, par. 1405)
2     Sec. 405. (a) Any person who engages in a calculated
3 criminal drug conspiracy, as defined in subsection (b), is
4 guilty of a Class X felony. The fine for violation of this
5 Section shall not be more than $500,000, and the offender shall
6 be subject to the forfeitures prescribed in subsection (c).
7     (b) For purposes of this Section section, a person engages
8 in a calculated criminal drug conspiracy when:
9         (1) he or she violates any of the provisions of
10     subsection (a) or (c) of Section 401 or subsection (a) of
11     Section 402; and
12         (2) such violation is a part of a conspiracy undertaken
13     or carried on with two or more other persons; and
14         (3) he or she obtains anything of value greater than
15     $500 from, or organizes, directs or finances such violation
16     or conspiracy.
17     (c) Any person who is convicted under this section of
18 engaging in a calculated criminal drug conspiracy shall forfeit
19 to the State of Illinois:
20         (1) the receipts obtained by him or her in such
21     conspiracy; and
22         (2) any of his or her interests in, claims against,
23     receipts from, or property or rights of any kind affording
24     a source of influence over, such conspiracy.
25     (d) The circuit court may enter such injunctions,
26 restraining orders, directions or prohibitions, or to take such

 

 

09600HB0445sam002 - 58 - LRB096 04780 RLC 25523 a

1 other actions, including the acceptance of satisfactory
2 performance bonds, in connection with any property, claim,
3 receipt, right or other interest subject to forfeiture under
4 this Section, as it deems proper.
5 (Source: P.A. 91-357, eff. 7-29-99.)
 
6     (720 ILCS 570/405.1)  (from Ch. 56 1/2, par. 1405.1)
7     Sec. 405.1. (a) Elements of the offense. A person commits
8 criminal drug conspiracy when, with the intent that an offense
9 set forth in Section 401, Section 402, or Section 407 of this
10 Act be committed, he or she agrees with another to the
11 commission of that offense. No person may be convicted of
12 conspiracy to commit such an offense unless an act in
13 furtherance of such agreement is alleged and proved to have
14 been committed by him or her or by a co-conspirator.
15     (b) Co-conspirators. It shall not be a defense to
16 conspiracy that the person or persons with whom the accused is
17 alleged to have conspired:
18         (1) Has not been prosecuted or convicted, or
19         (2) Has been convicted of a different offense, or
20         (3) Is not amenable to justice, or
21         (4) Has been acquitted, or
22         (5) Lacked the capacity to commit an offense.
23     (c) Sentence. A person convicted of criminal drug
24 conspiracy may be fined or imprisoned or both, but any term of
25 imprisonment imposed shall be not less than the minimum nor

 

 

09600HB0445sam002 - 59 - LRB096 04780 RLC 25523 a

1 more than the maximum provided for the offense which is the
2 object of the conspiracy.
3 (Source: P.A. 89-404, eff. 8-20-95; 90-593, eff. 6-19-98.)
 
4     (720 ILCS 570/410)  (from Ch. 56 1/2, par. 1410)
5     Sec. 410. (a) Whenever any person who has not previously
6 been convicted of, or placed on probation or court supervision
7 for any offense under this Act or any law of the United States
8 or of any State relating to cannabis or controlled substances,
9 pleads guilty to or is found guilty of possession of a
10 controlled or counterfeit substance under subsection (c) of
11 Section 402 or of unauthorized possession of prescription form
12 under Section 406.2, the court, without entering a judgment and
13 with the consent of such person, may sentence him or her to
14 probation.
15     (b) When a person is placed on probation, the court shall
16 enter an order specifying a period of probation of 24 months
17 and shall defer further proceedings in the case until the
18 conclusion of the period or until the filing of a petition
19 alleging violation of a term or condition of probation.
20     (c) The conditions of probation shall be that the person:
21 (1) not violate any criminal statute of any jurisdiction; (2)
22 refrain from possessing a firearm or other dangerous weapon;
23 (3) submit to periodic drug testing at a time and in a manner
24 as ordered by the court, but no less than 3 times during the
25 period of the probation, with the cost of the testing to be

 

 

09600HB0445sam002 - 60 - LRB096 04780 RLC 25523 a

1 paid by the probationer; and (4) perform no less than 30 hours
2 of community service, provided community service is available
3 in the jurisdiction and is funded and approved by the county
4 board.
5     (d) The court may, in addition to other conditions, require
6 that the person:
7         (1) make a report to and appear in person before or
8     participate with the court or such courts, person, or
9     social service agency as directed by the court in the order
10     of probation;
11         (2) pay a fine and costs;
12         (3) work or pursue a course of study or vocational
13     training;
14         (4) undergo medical or psychiatric treatment; or
15     treatment or rehabilitation approved by the Illinois
16     Department of Human Services;
17         (5) attend or reside in a facility established for the
18     instruction or residence of defendants on probation;
19         (6) support his or her dependents;
20         (6-5) refrain from having in his or her body the
21     presence of any illicit drug prohibited by the Cannabis
22     Control Act, the Illinois Controlled Substances Act, or the
23     Methamphetamine Control and Community Protection Act,
24     unless prescribed by a physician, and submit samples of his
25     or her blood or urine or both for tests to determine the
26     presence of any illicit drug;

 

 

09600HB0445sam002 - 61 - LRB096 04780 RLC 25523 a

1         (7) and in addition, if a minor:
2             (i) reside with his or her parents or in a foster
3         home;
4             (ii) attend school;
5             (iii) attend a non-residential program for youth;
6             (iv) contribute to his or her own support at home
7         or in a foster home.
8     (e) Upon violation of a term or condition of probation, the
9 court may enter a judgment on its original finding of guilt and
10 proceed as otherwise provided.
11     (f) Upon fulfillment of the terms and conditions of
12 probation, the court shall discharge the person and dismiss the
13 proceedings against him or her.
14     (g) A disposition of probation is considered to be a
15 conviction for the purposes of imposing the conditions of
16 probation and for appeal, however, discharge and dismissal
17 under this Section is not a conviction for purposes of this Act
18 or for purposes of disqualifications or disabilities imposed by
19 law upon conviction of a crime.
20     (h) There may be only one discharge and dismissal under
21 this Section, Section 10 of the Cannabis Control Act, or
22 Section 70 of the Methamphetamine Control and Community
23 Protection Act with respect to any person.
24     (i) If a person is convicted of an offense under this Act,
25 the Cannabis Control Act, or the Methamphetamine Control and
26 Community Protection Act within 5 years subsequent to a

 

 

09600HB0445sam002 - 62 - LRB096 04780 RLC 25523 a

1 discharge and dismissal under this Section, the discharge and
2 dismissal under this Section shall be admissible in the
3 sentencing proceeding for that conviction as evidence in
4 aggravation.
5 (Source: P.A. 94-556, eff. 9-11-05; 95-487, eff. 1-1-08.)
 
6     (720 ILCS 570/501)  (from Ch. 56 1/2, par. 1501)
7     Sec. 501. (a) It is hereby made the duty of the Department
8 of Financial and Professional Regulation and the Department of
9 State Police, and their agents, officers, and investigators, to
10 enforce all provisions of this Act, except those specifically
11 delegated, and to cooperate with all agencies charged with the
12 enforcement of the laws of the United States, or of any State,
13 relating to controlled substances. Only an agent, officer, or
14 investigator designated by the Director may: (1) for the
15 purpose of inspecting, copying, and verifying the correctness
16 of records, reports or other documents required to be kept or
17 made under this Act and otherwise facilitating the execution of
18 the functions of the Department of Financial and Professional
19 Regulation or the Department of State Police, be authorized in
20 accordance with this Section to enter controlled premises and
21 to conduct administrative inspections thereof and of the things
22 specified; or (2) execute and serve administrative inspection
23 notices, warrants, subpoenas, and summonses under the
24 authority of this State. Any inspection or administrative entry
25 of persons licensed by the Department shall be made in

 

 

09600HB0445sam002 - 63 - LRB096 04780 RLC 25523 a

1 accordance with subsection (bb) of Section 30-5 of the
2 Alcoholism and Other Drug Abuse and Dependency Act and the
3 rules and regulations promulgated thereunder.
4     (b) Administrative entries and inspections designated in
5 clause (1) of subsection (a) shall be carried out through
6 agents, officers, investigators and peace officers
7 (hereinafter referred to as "inspectors") designated by the
8 Director. Any inspector, upon stating his or her purpose and
9 presenting to the owner, operator, or agent in charge of the
10 premises (1) appropriate credentials and (2) a written notice
11 of his or her inspection authority (which notice, in the case
12 of an inspection requiring or in fact supported by an
13 administrative inspection warrant, shall consist of that
14 warrant), shall have the right to enter the premises and
15 conduct the inspection at reasonable times.
16     Inspectors appointed by the Director under this Section 501
17 are conservators of the peace and as such have all the powers
18 possessed by policemen in cities and by sheriffs, except that
19 they may exercise such powers anywhere in the State.
20     (c) Except as may otherwise be indicated in an applicable
21 inspection warrant, the inspector shall have the right:
22         (1) to inspect and copy records, reports and other
23     documents required to be kept or made under this Act;
24         (2) to inspect, within reasonable limits and in a
25     reasonable manner, controlled premises and all pertinent
26     equipment, finished and unfinished drugs and other

 

 

09600HB0445sam002 - 64 - LRB096 04780 RLC 25523 a

1     substances or materials, containers and labeling found
2     therein, and all other things therein (including records,
3     files, papers, processes, controls and facilities)
4     appropriate for verification of the records, reports and
5     documents referred to in item (1) or otherwise bearing on
6     the provisions of this Act; and
7         (3) to inventory any stock of any controlled substance.
8     (d) Except when the owner, operator, or agent in charge of
9 the controlled premises so consents in writing, no inspection
10 authorized by this Section shall extend to:
11         (1) financial data;
12         (2) sales data other than shipment data; or
13         (3) pricing data.
14     Any inspection or administrative entry of persons licensed
15 by the Department shall be made in accordance with subsection
16 (bb) of Section 30-5 of the Alcoholism and Other Drug Abuse and
17 Dependency Act and the rules and regulations promulgated
18 thereunder.
19     (e) Any agent, officer, investigator or peace officer
20 designated by the Director may (1) make seizure of property
21 pursuant to the provisions of this Act; and (2) perform such
22 other law enforcement duties as the Director shall designate.
23 It is hereby made the duty of all State's Attorneys to
24 prosecute violations of this Act and institute legal
25 proceedings as authorized under this Act.
26 (Source: P.A. 88-670, eff. 12-2-94; 89-202, eff. 10-1-95.)
 

 

 

09600HB0445sam002 - 65 - LRB096 04780 RLC 25523 a

1     (720 ILCS 570/501.1)  (from Ch. 56 1/2, par. 1501.1)
2     Sec. 501.1. Administrative Procedure Act. The Illinois
3 Administrative Procedure Act is hereby expressly adopted and
4 incorporated herein, but shall apply only to the Department of
5 Financial and Professional Regulation, as if all of the
6 provisions of that Act were included in this Act, except that
7 the provision of subsection (d) of Section 10-65 of the
8 Illinois Administrative Procedure Act which provides that at
9 hearings the licensee has the right to show compliance with all
10 lawful requirements for retention, continuation or renewal of
11 the license is specifically excluded. For the purposes of this
12 Act the notice required under Section 10-25 of the Illinois
13 Administrative Procedure Act is deemed sufficient when mailed
14 to the last known address of a party.
15 (Source: P.A. 88-45.)
 
16     (720 ILCS 570/505)  (from Ch. 56 1/2, par. 1505)
17     Sec. 505. (a) The following are subject to forfeiture:
18         (1) all substances which have been manufactured,
19     distributed, dispensed, or possessed in violation of this
20     Act;
21         (2) all raw materials, products and equipment of any
22     kind which are used, or intended for use in manufacturing,
23     distributing, dispensing, administering or possessing any
24     substance in violation of this Act;

 

 

09600HB0445sam002 - 66 - LRB096 04780 RLC 25523 a

1         (3) all conveyances, including aircraft, vehicles or
2     vessels, which are used, or intended for use, to transport,
3     or in any manner to facilitate the transportation, sale,
4     receipt, possession, or concealment of property described
5     in paragraphs (1) and (2), but:
6             (i) no conveyance used by any person as a common
7         carrier in the transaction of business as a common
8         carrier is subject to forfeiture under this Section
9         unless it appears that the owner or other person in
10         charge of the conveyance is a consenting party or privy
11         to a violation of this Act;
12             (ii) no conveyance is subject to forfeiture under
13         this Section by reason of any act or omission which the
14         owner proves to have been committed or omitted without
15         his or her knowledge or consent;
16             (iii) a forfeiture of a conveyance encumbered by a
17         bona fide security interest is subject to the interest
18         of the secured party if he or she neither had knowledge
19         of nor consented to the act or omission;
20         (4) all money, things of value, books, records, and
21     research products and materials including formulas,
22     microfilm, tapes, and data which are used, or intended to
23     be used in violation of this Act;
24         (5) everything of value furnished, or intended to be
25     furnished, in exchange for a substance in violation of this
26     Act, all proceeds traceable to such an exchange, and all

 

 

09600HB0445sam002 - 67 - LRB096 04780 RLC 25523 a

1     moneys, negotiable instruments, and securities used, or
2     intended to be used, to commit or in any manner to
3     facilitate any violation of this Act;
4         (6) all real property, including any right, title, and
5     interest (including, but not limited to, any leasehold
6     interest or the beneficial interest in a land trust) in the
7     whole of any lot or tract of land and any appurtenances or
8     improvements, which is used or intended to be used, in any
9     manner or part, to commit, or in any manner to facilitate
10     the commission of, any violation or act that constitutes a
11     violation of Section 401 or 405 of this Act or that is the
12     proceeds of any violation or act that constitutes a
13     violation of Section 401 or 405 of this Act.
14     (b) Property subject to forfeiture under this Act may be
15 seized by the Director or any peace officer upon process or
16 seizure warrant issued by any court having jurisdiction over
17 the property. Seizure by the Director or any peace officer
18 without process may be made:
19         (1) if the seizure is incident to inspection under an
20     administrative inspection warrant;
21         (2) if the property subject to seizure has been the
22     subject of a prior judgment in favor of the State in a
23     criminal proceeding, or in an injunction or forfeiture
24     proceeding based upon this Act or the Drug Asset Forfeiture
25     Procedure Act;
26         (3) if there is probable cause to believe that the

 

 

09600HB0445sam002 - 68 - LRB096 04780 RLC 25523 a

1     property is directly or indirectly dangerous to health or
2     safety;
3         (4) if there is probable cause to believe that the
4     property is subject to forfeiture under this Act and the
5     property is seized under circumstances in which a
6     warrantless seizure or arrest would be reasonable; or
7         (5) in accordance with the Code of Criminal Procedure
8     of 1963.
9     (c) In the event of seizure pursuant to subsection (b),
10 forfeiture proceedings shall be instituted in accordance with
11 the Drug Asset Forfeiture Procedure Act.
12     (d) Property taken or detained under this Section shall not
13 be subject to replevin, but is deemed to be in the custody of
14 the Director subject only to the order and judgments of the
15 circuit court having jurisdiction over the forfeiture
16 proceedings and the decisions of the State's Attorney under the
17 Drug Asset Forfeiture Procedure Act. When property is seized
18 under this Act, the seizing agency shall promptly conduct an
19 inventory of the seized property and estimate the property's
20 value, and shall forward a copy of the inventory of seized
21 property and the estimate of the property's value to the
22 Director. Upon receiving notice of seizure, the Director may:
23         (1) place the property under seal;
24         (2) remove the property to a place designated by the
25     Director;
26         (3) keep the property in the possession of the seizing

 

 

09600HB0445sam002 - 69 - LRB096 04780 RLC 25523 a

1     agency;
2         (4) remove the property to a storage area for
3     safekeeping or, if the property is a negotiable instrument
4     or money and is not needed for evidentiary purposes,
5     deposit it in an interest bearing account;
6         (5) place the property under constructive seizure by
7     posting notice of pending forfeiture on it, by giving
8     notice of pending forfeiture to its owners and interest
9     holders, or by filing notice of pending forfeiture in any
10     appropriate public record relating to the property; or
11         (6) provide for another agency or custodian, including
12     an owner, secured party, or lienholder, to take custody of
13     the property upon the terms and conditions set by the
14     Director.
15     (e) If the Department of Financial and Professional
16 Regulation suspends or revokes a registration, all controlled
17 substances owned or possessed by the registrant at the time of
18 suspension or the effective date of the revocation order may be
19 placed under seal. No disposition may be made of substances
20 under seal until the time for taking an appeal has elapsed or
21 until all appeals have been concluded unless a court, upon
22 application therefor, orders the sale of perishable substances
23 and the deposit of the proceeds of the sale with the court.
24 Upon a revocation rule becoming final, all substances may be
25 forfeited to the Department of Financial and Professional
26 Regulation.

 

 

09600HB0445sam002 - 70 - LRB096 04780 RLC 25523 a

1     (f) When property is forfeited under this Act the Director
2 shall sell all such property unless such property is required
3 by law to be destroyed or is harmful to the public, and shall
4 distribute the proceeds of the sale, together with any moneys
5 forfeited or seized, in accordance with subsection (g).
6 However, upon the application of the seizing agency or
7 prosecutor who was responsible for the investigation, arrest or
8 arrests and prosecution which lead to the forfeiture, the
9 Director may return any item of forfeited property to the
10 seizing agency or prosecutor for official use in the
11 enforcement of laws relating to cannabis or controlled
12 substances, if the agency or prosecutor can demonstrate that
13 the item requested would be useful to the agency or prosecutor
14 in their enforcement efforts. When any forfeited conveyance,
15 including an aircraft, vehicle, or vessel, is returned to the
16 seizing agency or prosecutor, the conveyance may be used
17 immediately in the enforcement of the criminal laws of this
18 State. Upon disposal, all proceeds from the sale of the
19 conveyance must be used for drug enforcement purposes. When any
20 real property returned to the seizing agency is sold by the
21 agency or its unit of government, the proceeds of the sale
22 shall be delivered to the Director and distributed in
23 accordance with subsection (g).
24     (g) All monies and the sale proceeds of all other property
25 forfeited and seized under this Act shall be distributed as
26 follows:

 

 

09600HB0445sam002 - 71 - LRB096 04780 RLC 25523 a

1         (1) 65% shall be distributed to the metropolitan
2     enforcement group, local, municipal, county, or state law
3     enforcement agency or agencies which conducted or
4     participated in the investigation resulting in the
5     forfeiture. The distribution shall bear a reasonable
6     relationship to the degree of direct participation of the
7     law enforcement agency in the effort resulting in the
8     forfeiture, taking into account the total value of the
9     property forfeited and the total law enforcement effort
10     with respect to the violation of the law upon which the
11     forfeiture is based. Amounts distributed to the agency or
12     agencies shall be used for the enforcement of laws
13     governing cannabis and controlled substances or for
14     security cameras used for the prevention or detection of
15     violence, except that amounts distributed to the Secretary
16     of State shall be deposited into the Secretary of State
17     Evidence Fund to be used as provided in Section 2-115 of
18     the Illinois Vehicle Code.
19         (2)(i) 12.5% shall be distributed to the Office of the
20     State's Attorney of the county in which the prosecution
21     resulting in the forfeiture was instituted, deposited in a
22     special fund in the county treasury and appropriated to the
23     State's Attorney for use in the enforcement of laws
24     governing cannabis and controlled substances. In counties
25     over 3,000,000 population, 25% will be distributed to the
26     Office of the State's Attorney for use in the enforcement

 

 

09600HB0445sam002 - 72 - LRB096 04780 RLC 25523 a

1     of laws governing cannabis and controlled substances. If
2     the prosecution is undertaken solely by the Attorney
3     General, the portion provided hereunder shall be
4     distributed to the Attorney General for use in the
5     enforcement of laws governing cannabis and controlled
6     substances.
7         (ii) 12.5% shall be distributed to the Office of the
8     State's Attorneys Appellate Prosecutor and deposited in
9     the Narcotics Profit Forfeiture Fund of that office to be
10     used for additional expenses incurred in the
11     investigation, prosecution and appeal of cases arising
12     under laws governing cannabis and controlled substances.
13     The Office of the State's Attorneys Appellate Prosecutor
14     shall not receive distribution from cases brought in
15     counties with over 3,000,000 population.
16         (3) 10% shall be retained by the Department of State
17     Police for expenses related to the administration and sale
18     of seized and forfeited property.
19     (h) Species of plants from which controlled substances in
20 Schedules I and II may be derived which have been planted or
21 cultivated in violation of this Act, or of which the owners or
22 cultivators are unknown, or which are wild growths, may be
23 seized and summarily forfeited to the State. The failure, upon
24 demand by the Director or any peace officer, of the person in
25 occupancy or in control of land or premises upon which the
26 species of plants are growing or being stored, to produce

 

 

09600HB0445sam002 - 73 - LRB096 04780 RLC 25523 a

1 registration, or proof that he or she is the holder thereof,
2 constitutes authority for the seizure and forfeiture of the
3 plants.
4 (Source: P.A. 94-1004, eff. 7-3-06.)
 
5     (720 ILCS 570/507)  (from Ch. 56 1/2, par. 1507)
6     Sec. 507. All rulings, final determinations, findings, and
7 conclusions of the Department of State Police, the Department
8 of Financial and Professional Regulation, and the Department of
9 Human Services of the State of Illinois under this Act are
10 final and conclusive decisions of the matters involved. Any
11 person aggrieved by the decision may obtain review of the
12 decision pursuant to the provisions of the Administrative
13 Review Law, as amended and the rules adopted pursuant thereto.
14 Pending final decision on such review, the acts, orders and
15 rulings of the Department shall remain in full force and effect
16 unless modified or suspended by order of court pending final
17 judicial decision. Pending final decision on such review, the
18 acts, orders, sanctions and rulings of the Department of
19 Financial and Professional Regulation regarding any
20 registration shall remain in full force and effect, unless
21 stayed by order of court. However, no stay of any decision of
22 the administrative agency shall issue unless the person
23 aggrieved by the decision establishes by a preponderance of the
24 evidence that good cause exists therefor. In determining good
25 cause, the court shall find that the aggrieved party has

 

 

09600HB0445sam002 - 74 - LRB096 04780 RLC 25523 a

1 established a substantial likelihood of prevailing on the
2 merits and that granting the stay will not have an injurious
3 effect on the general public. Good cause shall not be
4 established solely on the basis of hardships resulting from an
5 inability to engage in the registered activity pending a final
6 judicial decision.
7 (Source: P.A. 89-507, eff. 7-1-97.)
 
8     (720 ILCS 570/204 rep.)
9     (720 ILCS 570/206 rep.)
10     (720 ILCS 570/208 rep.)
11     (720 ILCS 570/210 rep.)
12     (720 ILCS 570/212 rep.)
13     (720 ILCS 570/213 rep.)
14     (720 ILCS 570/216 rep.)
15     (720 ILCS 570/217 rep.)
16     Section 10. The Illinois Controlled Substances Act is
17 amended by repealing Sections 204, 206, 208, 210, 212, 213,
18 216, and 217.
 
19     Section 99. Effective date. This Act takes effect upon
20 becoming law.".